Abbott Labs
ABT
$133.58-0.36 (-0.27%)
Jun 6, 2025, 4:00 PM
Financials
| 52Week High | 141.23 | 52Week Low | 99.71 |
| Beta | 0.72 | Current Ratio Annual | 1.67 |
| Current Ratio Quarterly | 1.78 | Gross Margin TTM | 56.10 |
| Market Cap | 232.41B | Net Profit Margin TTM | 31.89 |
| Operating Margin TTM | 16.33 | Price To Book | 4.76 |
| Price To Earnings TTM | 17.21 | Price To Free Cash Flow TTM | 34.91 |
| Price To Sales TTM | 5.49 | Quick Ratio Annual | 1.05 |
| Quick Ratio Quarterly | 1.09 | Return On Assets TTM | 17.41 |
| Return On Equity TTM | 30.76 | Return On Investment TTM | 23.21 |
| Revenue Growth3Y | -0.88 | Revenue Growth5Y | 5.63 |
| Revenue Growth Quarterly Yoy | 3.95 | Revenue Growth TTMYoy | 5.00 |
| Revenue Per Share TTM | 24.24 |
| Quarter | Funds | Added | Exited | Increased | Decreased | Unchanged | Shares | Value |
|---|---|---|---|---|---|---|---|---|
| Dec 31, 2024 | 3030 | 1 | 1 | 18 | 28 | 13 | 1.37B | $148.80B |
| Mar 31, 2025 | 2967 | 232 | 252 | 1065 | 1257 | 373 | 1.36B | $172.85B |
| Change | 63(2%) | 231(23100%) | 251(25100%) | 1.05K(5817%) | 1.23K(4389%) | 360(2769%) | 9.36M(1%) | $24.05B(16%) |